Actively Recruiting
Lower Silesia Cardiogenic Shock Initiative
Led by Wroclaw Medical University · Updated on 2025-04-02
50
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.
CONDITIONS
Official Title
Lower Silesia Cardiogenic Shock Initiative
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fulfilled definition of cardiogenic shock
- Age 18 - 60 years
- Shock duration below 24 hours
You will not qualify if you...
- History of cardiac arrest with anoxemic brain injury
- Irreversible multiorgan failure
- End stage of chronic diseases other than heart failure
- Neoplastic disease
- Lack of vascular access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Heart Disease of Wroclaw Medical University
Wroclaw, Poland, 50-556
Actively Recruiting
Research Team
W
Wiktor Kuliczkowski
CONTACT
M
Mateusz Sokolski
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here